30 June 2018 in European Journal of Pediatrics
1 January 2022 in Pediatrics International
21 September 2020 in Biomedicine Hub
Etilefrine, a sympathomimetic agent, is reportedly effective against postoperative chylothorax. However, its effectiveness in treating congenital chylothorax was unknown. We report herein a case of refractory congenital chylothorax treated with etilefrine in a late preterm neonate with massive fetal chylous pleural effusion. The chylothorax was unresponsive to previous treatments, including dietary and pharmacological treatment and thoracic duct ligation. The pleural effusion decreased after intravenous etilefrine was begun on day of life (DOL) 84 and resolved after the addition of chemical pleurodesis with OK-432 on DOL 90. This combination therapy may be a viable treatment option for cases of congenital chylothorax that are unresponsive to other treatments.
1 January 2022 in Pediatrics International
29 January 2022 in Pediatrics International
22 February 2019 in Archives of Disease in Childhood - Fetal and Neonatal Edition
A female infant was delivered vaginally at 22 weeks and 5 days of gestation with a birth weight of 480 g due to chorioamnionitis. Low-dose intravenous micafungin at 1 mg/kg/day was started for fungal prophylaxis as part of the routine treatment. On day 4, white, chalky lesions were noted on the chest, axillae, back and umbilicus figure 1. Dermatitis on the right femur progressed to a crusty lesion figure 2. A …